- KR₩31bn
- KR₩28bn
- KR₩24bn
Annual balance sheet for BioInfra Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,174 | 5,782 | 7,362 | 14,694 | 11,032 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,177 | 6,840 | 5,260 | 6,608 | 3,616 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 9,461 | 22,996 | 12,867 | 21,408 | 14,764 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,667 | 7,865 | 17,413 | 18,868 | 18,833 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 17,448 | 33,740 | 32,589 | 47,004 | 41,121 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11,533 | 11,154 | 6,375 | 8,485 | 9,219 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 13,127 | 22,877 | 14,680 | 13,030 | 13,553 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Total Equity | 4,322 | 10,862 | 17,910 | 33,974 | 27,568 |
Total Liabilities & Shareholders' Equity | 17,448 | 33,740 | 32,589 | 47,004 | 41,121 |
Total Common Shares Outstanding |